CT screening for lung cancer
Screening is the process of identifying disease in people who do not yet exhibit symptoms. Routine screening tests for cancer include mammograms for breast cancer, colonoscopies for colon cancer and PAP smears for cervical cancer.
The use of low-dose, helical computerized tomography (CT) scans to detect lung cancer in those at high risk was scientifically validated in research results announced in November 2010 and published in June 2011. Since that time, lung cancer screening centers using responsible practices to screen those at high risk are opening all over the country.
CT screening can find lung cancer when it is at its earliest and most curable stage. Are you at high risk for lung cancer? If so, do you wonder where to get screened? This information will inform you so you can talk with your doctor about your risk and screening.
Learn about CT screening for lung cancer
Screening validation studies
National Lung Screening Trial Research Team. 2011. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening: Results of the National Lung Screening Trial. N Engl J Med; 365(5):395-409.
van den Bergh et al. 2011. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J; 38: 154–161
The International Early Lung Cancer Action Program Investigators. 2006. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med; 355(17): 1763-1771.
Guidelines for lung cancer screening
National Comprehensive Cancer Network. 2012. Lung Cancer Screening: NCCN Guidelines for Patients. Version 1.2012.
Ensuring excellence in screening
Lung Cancer Alliance. 2012. National Framework for Excellence In Lung Cancer Screening and Continuum of Care.
Where to be screened
Lung Cancer Alliance's Screen for Lung Cancer website.
Other studies related to lung cancer screening
Pyenson et al. 2012. An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost. Health Aff; 31(4): 770–779.
Goldberg et al. 2010. An Actuarial Approach to Comparing Early Stage and Late Stage Lung Cancer Mortality and Survival. PHM; Vol 13:1.